Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
04/2004
04/20/2004US6723876 Process for the integrated preparation of ammonia and urea
04/20/2004US6723875 Process to prepare alkyl-ureas from O,S-dimethyl dithiocarbonate
04/20/2004US6723868 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/20/2004CA2215585C Practical synthesis of urea derivatives
04/15/2004WO2004009558A3 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
04/15/2004WO2003080554A3 Iodinated triglyceride analogs
04/15/2004US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups
04/15/2004US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents
04/15/2004US20040072690 Such as (R)-3-(4-(2-(3-(2,4-difluorophenyl)-1-heptylureido) ethoxy)phenyl)-2-ethoxypropionic acid; for prophylaxis/therapy of diabetes/hyperlipidemia
04/15/2004DE10246434A1 New N-(2-chloro-4-fluorobenzoyl)-N'-phenyl-urea derivatives, are glycogenolysis inhibitors useful e.g. for treating type II diabetes, arteriosclerosis, ischemia, angina pectoris or tumor diseases
04/14/2004EP1406865A2 Succinic acid derivatives
04/14/2004CN1488624A Novel substituted propanamide benzoyl urea derivatives, medicinal composition containg same and use thereof
04/13/2004US6720421 Storage stability: good raw-stock storability before recording and good image storability after recording
04/08/2004WO2004028538A1 Small organic molecules that increase the activity of gelatinase a in ocular cells
04/08/2004WO2003051276B1 Therapeutic heterocycles
04/08/2004WO2003027064B1 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical co mpositions containing the same
04/08/2004US20040068017 Small organic molecules that increase the activity of Gelatinase A in ocular cells
04/08/2004US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
04/08/2004US20040067927 Substituted alkyldiamines
04/08/2004US20040067367 Low-cure powder coatings and methods for using the same
04/08/2004CA2500200A1 Small organic molecules that increase the activity of gelatinase a in ocular cells
04/07/2004EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
04/07/2004EP1404649A1 New phenylalkyloxy-phenyl derivatives
04/07/2004EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
04/07/2004EP1086077B1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application
04/07/2004CN1486974A New benzoyl urea compound and its synthesis and application
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors
04/01/2004WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2004WO2003082777A3 Novel glucocorticoid receptor ligands
04/01/2004WO2003075853A3 Cyclic derivatives as modulators of chemokine receptor activity
04/01/2004WO2002076402A3 Fatty amine drug conjugates
04/01/2004US20040063963 Dimerization; oxidation coupling of naphthol in presence of complex catalyst of copper chloride-tetramethylethylenediamine
04/01/2004US20040063894 Polyaspartate resins with good hardness and flexibility
04/01/2004US20040063866 The compositions comprise a polyepoxide and a material having the structure wherein R1 is an organic radical having 6 to 25 carbon atoms; R2 is an organic radical having 1 to 20 carbon atoms; R3 and R4 are independently alkyl or phenyl groups
04/01/2004US20040063786 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063742 Such as 5-(4-Chlorophenyl)-8-methyl-6,7,8,9-tetrahydro-1-H-pyrrolo(3.2-h)isoquinoline-2,3-dione-3-oxime-(phenyl))urea; kits; drug screening
04/01/2004US20040063643 Bombesin antagonists
04/01/2004CA2498662A1 Phenol derivatives and their use as rotamase inhibitors
03/2004
03/31/2004EP1403245A1 Polyaspartate resins with good hardness and flexibility
03/31/2004EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors
03/31/2004EP1015421B1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments
03/31/2004CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis
03/31/2004CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same
03/30/2004US6713650 ABCA-1 elevating compounds
03/26/2004CA2442409A1 Polyaspartate resins with good hardness and flexibility
03/25/2004WO2003102044A3 Low-cure powder coatings and methods for using the same
03/25/2004US20040058904 Antiinflammatory agents; autoimmune disease
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/24/2004EP1399426A2 Compounds, compositions and methods for modulating beta-amyloid production
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/23/2004US6710085 Applying to plants, seeds; reaction product of formic acid and urea
03/18/2004WO2004022530A1 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
03/18/2004WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers
03/18/2004WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors
03/18/2004WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040054190 Imaging prostate cancer
03/18/2004US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053890 Naphthalene derivatives
03/18/2004CA2497322A1 Urea-, glycerate- and , hydroxyamide-headed hydrocarbon chain lyotropic phase forming surfactants
03/18/2004CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers
03/17/2004EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion
03/17/2004CN1483024A Vla-4 inhibitors
03/16/2004US6706749 Substituted phenyl derivatives, their preparation and use
03/16/2004US6706744 Hypoglycemic agents; antidiabetic agents
03/16/2004US6706715 Reversible inhibitors of the blood clotting enzyme factor viia
03/11/2004WO2004020400A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs
03/11/2004WO2003097587A3 Gelling agents
03/11/2004WO2003089615A3 Antiviral inhibitions of capsid proteins
03/11/2004WO2003088915A3 Novel sodium channel blockers
03/11/2004WO2003002524A3 Urea derivatives with antiproteolytic activity
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040048909 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis
03/11/2004US20040048904 E.g., 1-(pyridin-4-ylcarbamoyl)-1,2,3,6- tetrahydropyridine hydrochloride; treating and/or preventing amnesia or dementia
03/11/2004US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
03/11/2004US20040048834 Antitumoral compounds
03/11/2004CA2496470A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs
03/10/2004EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production
03/10/2004EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
03/10/2004EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
03/10/2004EP1085010B1 Phenylacetylene derivatives and agricultural/horticultural bactericides
03/10/2004EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii
03/10/2004CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours
03/03/2004EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140498C Novel antiarrhythmic compounds
03/02/2004US6699904 PPAR agonists
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
02/2004
02/26/2004US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
02/26/2004US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease
02/26/2004US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours
02/26/2004US20040037022 Aminoalcohol derivatives
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's)
02/25/2004EP1073629B1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 99